Accreditation Statement and Credit Designation

European Accreditation Council for Continuing Medical Education (UEMS/EACCME) 

The Annual Global Meeting of the International Gynecologic Cancer Society, Dublin, Ireland 16/10/2024 – 18/10/2024, has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 15.0 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

American Medical Association (AMA) 

Through an agreement between the European Union of Medical Specialists and the American Medical Association, physicians may convert EACCME credits to an equivalent number of AMA PRA Category 1 Credits™. Information on the process to convert EACCME credit to AMA credit can be found at https://www.ama-assn.org/education/ama-pra-credit-system/agreement-european-union-medical-specialties-uems  

Royal College of Physicians and Surgeons of Canada  

Live educational activities, occurring outside of Canada, recognized by the UEMS-EACCME for ECMEC credits are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of The Royal College of Physicians and Surgeons of Canada. For more information, visit: www.royalcollege.ca/rcsite/cpd/providers/international-accreditation-agreements-e 

Credit Breakdown  

Each participant should claim only those hours of credit that he/she actually spent in the educational activity.

Day	Maximum Credits
16/10/2024	4.5
17/10/2024	5.0
18/10/2024	5.5
Total Credits:	15.0

Educational Objectives   

After participating in this educational event, learners should be able to:

• Address individual needs in compliance with their Continuous Professional Development (CPD) plan.
• Describe the latest advancements in treatment strategies for gynecologic cancers, including endometrial, ovarian, and cervical cancer.
• Identify and utilize educational resources, networks, and platforms for the exchange of knowledge and continuous learning in gynecologic oncology.
• Discuss the integration of translational research and clinical trials into practice for the management of gynecologic cancers.
• Evaluate new developments and innovations in surgery, radiotherapy, chemotherapy, and immunotherapy for the treatment of gynecologic malignancies.
• Analyze the current status and future directions of neoadjuvant chemotherapy and other emerging therapies in gynecologic cancers.
• Strengthen professional relationships and collaborations with colleagues and experts from around the world in the field of gynecologic oncology.

Target Audience   

IGCS 2024 is the global meeting place for clinical practitioners, researchers, and clinical researchers in the field of gynecological oncology and its sub-specialties. Because of the diverse, clinically focused educational offering, participants are able to tailor the curriculum to meet the needs of international clinicians of all levels of experience.

To Receive Your CME/CPD Certificate

The CME/CPD certificate will be available after completing the online evaluation and credit claiming procedure. The process takes about 5 minutes. We thank you for your feedback as it is an important part of CME/CPD accreditation and helps improve future educational offerings.

Before 18th of January 2025:

1. Access the online system via the following link
2. Complete the anonymous online evaluation
3. Enter your username (conference registration email) and password (Registration ID) during the credit-claiming process
4. Complete the credit claim form and submit

• The CME/CPD certificate will be available for download; retain for your personal records
• Please note that web browsers Mozilla Firefox 2.X or higher, or Google Chrome are recommended 
• Kindly note that the IGCS 2024 online evaluation will be active on the last day of the meeting. You will then be able to access it and claim your CME/CPD certificate. 

Disclosure and Resolution of Personal Conflicts of Interest  

In accordance with CME/CPD accreditation criteria and standards for commercial support to ensure balance, independence, objectivity, and scientific rigor, those in control of the educational content must disclose potential or actual conflicts of interest. Disclosure information is evaluated and conflicts of interest are resolved. Disclosure is made to participants prior to the activity. Participants will be asked on the evaluation to assess the objectivity and independence of the event.

• View disclosure information HERE.

Industry Support Disclosure  

This event is supported, in part, by funding from industry. All support is managed in strict accordance with CME/CPD accreditation criteria and standards for commercial support. Appropriate acknowledgement of all supporting organisations is made in the programme guide, on the event website, and with signage during the event.

• View a list of all industry supporters here.
• View detailed programmes for all Industry Sessions here.

Commitment to the Highest Standards in CME/CPD

Kenes is committed to being a valuable and knowledgeable partner in the design and delivery of educationally strong, independent, transparent, and effective CME/CPD programmes. Kenes is a proud member of the Good CME Practice Group (gCMEp), a member organisation contributing to improving health outcomes by: 

• Championing best practices in CME/CPD 
• Maintaining and improving standards  
• Mentoring and educating  
• Working in collaboration with critical stakeholders  

Membership in the Good CME Practice Group illustrates Kenes commitment to high standards and knowledgeable partnership with its clients in the design and delivery of medical events.